Aline Sherwood

Inga fler pågående positioner

Förmögenhet: - $ per 2026-06-30

56 år

Health Technology

Consumer Services

Profil

Aline B. Sherwood worked as Senior Director-Strategic Communications at Cognition Therapeutics, Inc. from 2023 to 2025.
Served as Independent Director at Bio-Path Holdings, Inc. from 2022 to 2025.
Held the position of Head-Communications at The Liposome Co., Inc. Owned Scienta Communications LLC.
Completed undergraduate education at Beloit College.

Kända innehav i offentliga företag

Företag	Datum	Antal aktier	Värdering	Värderingsdatum
BIO-PATH HOLDINGS, INC. -.--%	2025-03-21	0 ( -.--% )	- $	2026-06-30

Tidigare kända positioner av Aline Sherwood

Företag	Position	Slut
COGNITION THERAPEUTICS, INC.	Företagsledare/Principal	2025-08-01
BIO-PATH HOLDINGS, INC.	Direktör/Styrelseledamot	2025-06-21
The Liposome Co., Inc. The Liposome Co., Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures, and markets therapeutic products to treat cancer and related diseases	Offentlig kommunikationskontakt	-
Scienta Communications LLC	Företagsledare/Principal	-

Se detaljerna i Aline Sherwoods erfarenhet

Aline Sherwoods utbildningar

Erfarenheter
Innehade positioner

Aktiva

Inaktiva

Börsnoterade företag

Privata företag

Se detaljerna i Aline Sherwoods erfarenhet

Relationer

Första gradens relationer

Företag kopplade till första graden

Man

Kvinna

Styrelseledamöter

Chefer

Se det personliga nätverket

Kopplade företag

Privata företag	5
The Liposome Co., Inc. The Liposome Co., Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures, and markets therapeutic products to treat cancer and related diseases	Health Technology
Bio-Path Holdings, Inc. Bio-Path Holdings, Inc. BiotechnologyHealth Technology Operates as a clinical stage biotechnology company, which focuses on developing therapeutic products	Health Technology
Beloit College Beloit College Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Cognition Therapeutics, Inc. Cognition Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical stage neuroscience company that develops drugs to help restore normal cellular damage responses in neurodegenerative and neuro-ophthalmic disorders	Health Technology
Scienta Communications LLC